Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ennio Iezzi

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Frontiers in Molecular Neuroscience|December 7, 2017
Amyloid-β Homeostasis Bridges Inflammation, Synaptic Plasticity Deficits and Cognitive Dysfunction in Multiple SclerosisMario Stampanoni Bassi, Sara Garofalo, Girolama A Marfia, et al.
Journal of Neurology|September 1, 2018
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease courseMario Stampanoni Bassi, Ennio Iezzi, Doriana Landi, et al.
Journal of Neuroinflammation|April 16, 2018
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Girolama A Marfia, et al.
Frontiers in Neurology|February 15, 2019
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple SclerosisMario Stampanoni Bassi, Antonietta Gentile, Ennio Iezzi, et al.
European Journal of Neurology|September 27, 2023
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosisMario Stampanoni Bassi, Luana Gilio, Fabio Buttari, et al.
Frontiers in Aging Neuroscience|September 27, 2021
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple SclerosisMario Stampanoni Bassi, Luana Gilio, Ennio Iezzi, et al.
Therapeutic Advances in Neurological Disorders|December 21, 2020
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patientsMario Stampanoni Bassi, Jelena Drulovic, Tatjana Pekmezovic, et al.
Biomolecules|February 25, 2022
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple SclerosisFederica Azzolini, Luana Gilio, Luigi Pavone, et al.
Biomedicines|January 21, 2023
Osteopontin Is Associated with Multiple Sclerosis RelapsesMario Stampanoni Bassi, Fabio Buttari, Luana Gilio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2023
Genetic regulation of IL-8 influences disease presentation of multiple sclerosisEttore Dolcetti, Antonio Bruno, Federica Azzolini, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Frontiers in Molecular Neuroscience|December 7, 2017
Amyloid-β Homeostasis Bridges Inflammation, Synaptic Plasticity Deficits and Cognitive Dysfunction in Multiple SclerosisMario Stampanoni Bassi, Sara Garofalo, Girolama A Marfia, et al.
Journal of Neurology|September 1, 2018
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease courseMario Stampanoni Bassi, Ennio Iezzi, Doriana Landi, et al.
Journal of Neuroinflammation|April 16, 2018
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Girolama A Marfia, et al.
Frontiers in Neurology|February 15, 2019
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple SclerosisMario Stampanoni Bassi, Antonietta Gentile, Ennio Iezzi, et al.
European Journal of Neurology|September 27, 2023
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosisMario Stampanoni Bassi, Luana Gilio, Fabio Buttari, et al.
Frontiers in Aging Neuroscience|September 27, 2021
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple SclerosisMario Stampanoni Bassi, Luana Gilio, Ennio Iezzi, et al.
Therapeutic Advances in Neurological Disorders|December 21, 2020
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patientsMario Stampanoni Bassi, Jelena Drulovic, Tatjana Pekmezovic, et al.
Biomolecules|February 25, 2022
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple SclerosisFederica Azzolini, Luana Gilio, Luigi Pavone, et al.
Biomedicines|January 21, 2023
Osteopontin Is Associated with Multiple Sclerosis RelapsesMario Stampanoni Bassi, Fabio Buttari, Luana Gilio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2023
Genetic regulation of IL-8 influences disease presentation of multiple sclerosisEttore Dolcetti, Antonio Bruno, Federica Azzolini, et al.
Pageof 5